Loading data for GNMX — first visit, this takes a few seconds.
Corgi Genomics & Precisio... (GNMX)
Cboe US: GNMX
· Precio en tiempo real · USD
35.84
+0.71 (2.02%)
Al cierre: Aug 21, 2026, 6:02 PM
Corgi Genomics & Precision Medicine ETF (GNMX): precio, posiciones y análisis del ETF
2.02% (1D)
No hay datos disponibles
| Precio de compra | 17.32 |
| Capitalización de mercado | n/a |
| AUM | 1.63M |
| NAV | 35.12 |
| Beta | n/a |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | May 5, 2026 |
| Precio de venta | 54.28 |
| Volumen | 934 |
| Volumen medio (20D) | 661 |
| Abierto | 35.46 |
| Cierre anterior | 35.13 |
| Rango del día | 35.46 - 35.84 |
| Rango de 52 semanas | 23.88 - 35.84 |
| Participaciones | n/a |
| Relación de gastos | 0.35% |
Acerca de GNMX
The fund is an ETF that seeks to meet its objective by having Corgi Strategies, LLC actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the research, development, and commercialization of genomics and precision medicine technologies that enable improved disease detection, identifying and grouping patients based on genetic, molecular, or clinical characteristics to guide treatment decisions, targeted therapies, and data-driven healthcare. It is non-diversified.
Clase de activo Equity
Símbolo bursátil GNMX
Fecha de inicio May 5, 2026
Proveedor Corgi Funds
Sitio web Página de inicio del fondo
Intercambio Cboe US
Las 10 principales participaciones 44.19% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Thermo Fisher Scient... | TMO | 9.28% |
| Vertex Pharmaceutica... | VRTX | 6.75% |
| Illumina Inc | ILMN | 4.56% |
| Guardant Health Inc | GH | 4.26% |
| Revolution Medicines... | RVMD | 3.92% |
| Incyte Corp | INCY | 3.38% |
| First American Gover... | FGXXX | 3.25% |
| Moderna Inc | MRNA | 3.06% |
| Genmab As Adr | GMAB | 2.96% |
| Alnylam Pharmaceutic... | ALNY | 2.77% |